Literature DB >> 2318976

Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit.

J J Badimon1, L Badimon, V Fuster.   

Abstract

The effects of homologous plasma HDL and VHDL fractions on established atherosclerotic lesions were studied in cholesterol-fed rabbits. Atherosclerosis was induced by feeding the animals a 0.5% cholesterol-rich diet for 60 d (group 1). Another group of animals were maintained on the same diet for 90 d (group 2). A third group was also fed the same diet for 90 d but received 50 mg HDL-VHDL protein per wk (isolated from normolipemic rabbit plasma) during the last 30 d (group 3). Aortic atherosclerotic involvement at the completion of the study was 34 +/- 4% in group 1, 38.8 +/- 5% in group 2, and 17.8 +/- 4% in group 3 (P less than 0.005). Aortic lipid deposition was also significantly reduced in group 3 compared with group 1 (studied at only 60 d) and group 2. This is the first in vivo, prospective evidence of the antiatherogenic effect of HDL-VHDL against preexisting atherosclerosis. Our results showed that HDL plasma fractions were able to induce regression of established aortic fatty streaks and lipid deposits. Our results suggest that it may be possible not only to inhibit progression but even to reduce established atherosclerotic lesions by HDL administration.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2318976      PMCID: PMC296557          DOI: 10.1172/JCI114558

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  44 in total

1.  Technics for studying atherosclerotic lesions.

Authors:  R L HOLMAN; H C McGILL; J P STRONG; J C GEER
Journal:  Lab Invest       Date:  1958 Jan-Feb       Impact factor: 5.662

2.  High density lipoproteins reduce the uptake of low density lipoproteins by human endothelial cells in culture.

Authors:  O Stein; Y Stein
Journal:  Biochim Biophys Acta       Date:  1976-05-27

3.  A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples.

Authors:  M A Markwell; S M Haas; L L Bieber; N E Tolbert
Journal:  Anal Biochem       Date:  1978-06-15       Impact factor: 3.365

Review 4.  The anatomy and physiology of reverse cholesterol transport.

Authors:  D Reichl; N E Miller
Journal:  Clin Sci (Lond)       Date:  1986-03       Impact factor: 6.124

5.  A comparative study on the removal of cellular lipids from Landschütz ascites cells by human plasma apolipoproteins.

Authors:  R L Jackson; A M Gotto; O Stein; Y Stein
Journal:  J Biol Chem       Date:  1975-09-25       Impact factor: 5.157

6.  LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture.

Authors:  J R Hessler; A L Robertson; G M Chisolm
Journal:  Atherosclerosis       Date:  1979-03       Impact factor: 5.162

7.  Purification and characterization of lipid transfer protein(s) from human lipoprotein-deficient plasma.

Authors:  R E Morton; D B Zilversmit
Journal:  J Lipid Res       Date:  1982-09       Impact factor: 5.922

8.  High density lipoprotein plasma fractions inhibit aortic fatty streaks in cholesterol-fed rabbits.

Authors:  J J Badimon; L Badimon; A Galvez; R Dische; V Fuster
Journal:  Lab Invest       Date:  1989-03       Impact factor: 5.662

9.  Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts.

Authors:  D H Blankenhorn; S A Nessim; R L Johnson; M E Sanmarco; S P Azen; L Cashin-Hemphill
Journal:  JAMA       Date:  1987-06-19       Impact factor: 56.272

10.  Verapamil suppresses atherosclerosis in cholesterol-fed rabbits.

Authors:  J L Rouleau; W W Parmley; J Stevens; J Wikman-Coffelt; R Sievers; R W Mahley; R J Havel
Journal:  J Am Coll Cardiol       Date:  1983-06       Impact factor: 24.094

View more
  162 in total

Review 1.  Postprandial lipemia and coronary risk.

Authors:  W Patsch; H Esterbauer; B Föger; J R Patsch
Journal:  Curr Atheroscler Rep       Date:  2000-05       Impact factor: 5.113

2.  Acute Coronary Syndromes: Molecular Basis for Cardiac Risk Factors.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1997       Impact factor: 2.300

3.  Biochemical characterization of cholesteryl ester transfer protein inhibitors.

Authors:  Mollie Ranalletta; Kathleen K Bierilo; Ying Chen; Denise Milot; Qing Chen; Elaine Tung; Caroline Houde; Nadine H Elowe; Margarita Garcia-Calvo; Gene Porter; Suzanne Eveland; Betsy Frantz-Wattley; Mike Kavana; George Addona; Peter Sinclair; Carl Sparrow; Edward A O'Neill; Ken S Koblan; Ayesha Sitlani; Brian Hubbard; Timothy S Fisher
Journal:  J Lipid Res       Date:  2010-05-10       Impact factor: 5.922

4.  An integrated approach for the mechanisms responsible for atherosclerotic plaque regression.

Authors:  Andrew A Francis; Grant N Pierce
Journal:  Exp Clin Cardiol       Date:  2011

5.  Oral supplement of six selective amino acids arrest progression renal failure in uremic patients.

Authors:  Hippocrates Yatzidis
Journal:  Int Urol Nephrol       Date:  2004       Impact factor: 2.370

Review 6.  Anti-inflammatory properties of HDL.

Authors:  Benjamin J Ansell; Mohamad Navab; Karol E Watson; Gregg C Fonarow; Alan M Fogelman
Journal:  Rev Endocr Metab Disord       Date:  2004-12       Impact factor: 6.514

7.  Complex genetic architecture revealed by analysis of high-density lipoprotein cholesterol in chromosome substitution strains and F2 crosses.

Authors:  Ioannis M Stylianou; Shirng-Wern Tsaih; Keith DiPetrillo; Naoki Ishimori; Renhua Li; Beverly Paigen; Gary Churchill
Journal:  Genetics       Date:  2006-09-01       Impact factor: 4.562

8.  Site-specific nitration of apolipoprotein A-I at tyrosine 166 is both abundant within human atherosclerotic plaque and dysfunctional.

Authors:  Joseph A DiDonato; Kulwant Aulak; Ying Huang; Matthew Wagner; Gary Gerstenecker; Celalettin Topbas; Valentin Gogonea; Anthony J DiDonato; W H Wilson Tang; Ryan A Mehl; Paul L Fox; Edward F Plow; Jonathan D Smith; Edward A Fisher; Stanley L Hazen
Journal:  J Biol Chem       Date:  2014-02-20       Impact factor: 5.157

Review 9.  Multiple indications for anti-inflammatory apolipoprotein mimetic peptides.

Authors:  Brian J Van Lenten; Mohamad Navab; G M Anantharamaiah; Georgette M Buga; Srinivasa T Reddy; Alan M Fogelman
Journal:  Curr Opin Investig Drugs       Date:  2008-11

10.  Selective delipidation of plasma HDL enhances reverse cholesterol transport in vivo.

Authors:  Frank M Sacks; Lawrence L Rudel; Adam Conner; Hassibullah Akeefe; Gerhard Kostner; Talal Baki; George Rothblat; Margarita de la Llera-Moya; Bela Asztalos; Timothy Perlman; Chunyu Zheng; Petar Alaupovic; Jo-Ann B Maltais; H Bryan Brewer
Journal:  J Lipid Res       Date:  2009-01-14       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.